Dernières nouvelles pour Ferrari (NYSE:RACE) Stock

Ferrari

Ferrari designs, engineers, and manufactures some of the world's most expensive luxury cars. With supply carefully controlled to be below demand and a brand steeped in decades of motor racing history, a Ferrari is viewed as a status symbol. In 2024, the company sold 13,752 vehicles at an average price over EUR 480,000 with more than 70% of its vehicles being sold to existing Ferrari clients. Eighty-six percent of revenue is generated from the sale of cars and spare parts and 10% from sponsorship, commercial, and brand activities including racing and lifestyle activities. In 2024, the Europe, Middle East, and Africa region accounted for 47% of revenue, the Americas was 33%, mainland China, Hong Kong, and Taiwan was 8%, and the rest of Asia was 12%.

Ferrari NV

Race Oncology Ltd

WIIM

YPF shares are trading lower amid a U.S. judge's order for Argentina to transfer its 51% stake in the company to satisfy a $16.1 billion court judgment against the country.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>B of A Securities analyst Jason Gerberry downgraded ProKidney Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) from Neutral to Underperform and lowered the price target from $3 to $1. ProKidney shares closed at $0.6687 on Friday. <a href="https://www.benzinga.com/quote/PROK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>D. Boral Capital analyst Jason Kolbert downgraded the rating for CorMedix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>) from Buy to Hold. Cormedix shares closed at $12.50 on Friday. <a href="https://www.benzinga.com/quote/CRMD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital analyst John McNulty downgraded Tronox Holdings plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>) from Market Perform to Underperform and lowered the price target from $7 to $3. Tronox Holdings shares closed at $5.64 on Friday. <a href="https://www.benzinga.com/quote/TROX/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying CRMD stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/CRMD/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="578" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30131626/image-446-1024x578.png" alt="" class="wp-image-967338" style="width:632px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30131626/image-446-1024x578.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30131626/image-446-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30131626/image-446-768x434.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30131626/image-446.png 1110w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/46136470/jim-cramer-just-revealed-1-oil-stock-he-actually-wants-to-own"> Jim Cramer Just Revealed 1 Oil Stock He Actually Wants To Own</a> </li>
</ul>
Photo via Shutterstock

News

Downgrades

Markets

Analyst Ratings

Trading Ideas

CRMD

PROK

TROX

This CorMedix Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday

Network-1 Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTIP#NYSE">NTIP</a>) announced today that it has initiated patent litigation against Samsung Electronics Co., LTD and Samsung Electronics America, Inc. (collectively, "Samsung") in the United States District Court for the Eastern District of Texas for infringement of U.S. Patent No. 11,233,780, U.S. Patent No. 11.916,893, U.S. Patent No. 12,207,094, U.S. Patent No. 12,166,869, U.S. Patent No.11,606,204, and U.S. Patent No. 11.973,864 (collectively, the "Patents-in-Suit").
The lawsuit alleges that Samsung infringes the Patents-in-Suit by supporting certain eSIM (embedded Subscriber Identification Module) and 5G technologies in its mobile devices, including its Galaxy smartphones, watches and tablets (the "Accused Products"). The Accused Products operate consistent with certain GSMA and ETSI industry standards.
The Patents-in-Suit are part of the M2M/IoT patent portfolio acquired by Network-1 in December 2017 (the "M2M/IoT Patent Portfolio"). The M2M/IoT Patent Portfolio relates to, among other things, enabling technology for authenticating and using eSIM technology in Internet of Things ("IoT"), Machine-to-Machine, and other mobile devices, including smartphones, tablets, watches, computers and automobiles. Patents in the M2M/IoT Patent Portfolio also relate to enabling technologies for 5G network authentication used in consumer and M2M devices (including smartphones), and the latest available Internet transport layer security solutions.
A study by the Trusted Connectivity Alliance (TCA) found that 2024 was a landmark year of growth across the global eSIM ecosystem during which the volume of eSIM device shipments surpassed 500 million units with eSIM profile downloads increasing by 56%.
Network-1's M2M/IoT Patent Portfolio includes forty-one (41) issued U.S. patents (and 6 pending applications), plus fifteen (15) issued non-U.S. patents. The patent terms of the MTM/IoT Patent Portfolio are currently expected to extend until 2033-2034. Network-1 has been developing the portfolio since its acquisition and anticipates further issuances of additional claims.
The M2M/IoT Patent Portfolio is available for licensing to firms that make use of the technologies covered by its patents, including eSIM and 5G technologies covered by the relevant GSMA and ETSI standards, as implemented in Internet of Things and M2M products as well as devices utilizing 5G.
 &nbsp;

Legal

NTIP

SSNLF

Network-1 Initiated Patent Litigation Against Samsung For Patent Infringement Over eSIM And 5G Technologies In Galaxy Devices

RDDT

Reddit shares are trading higher after Similarweb data showed rising app store downloads in recent months.

Argenx SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) stock is trading lower on Monday after the U.S. Food and Drug Administration (FDA) signaled serious risks/safety identified by the reporting system for Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase).
The FDA highlighted the severe worsening of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). CIDP is an immune-mediated polyneuropathy marked by nerve roots and peripheral nerve inflammation.
The FDA <a target="_blank" href="https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/january-march-2025-potential-signals-serious-risksnew-safety-information-identified-fda-adverse?Fds-Load-Behavior=force-external" rel="noreferrer noopener">noted</a> it is evaluating the need for possible regulatory action. Most recently, the European Commission approved Vyvgart 1000mg for subcutaneous (SC) injection as a monotherapy for adult patients with progressive or relapsing active CIDP after prior treatment with <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/g46033347/argenx-announces-european-commission-approval-of-vyvgart-subcutaneous-injection-for-chronic-inflam" rel="noreferrer noopener">corticosteroids or immunoglobulins</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/health-care/25/06/46175014/amgens-gastric-cancer-drug-improves-survival-in-phase-3-notes-ocular-side-effects" rel="noreferrer noopener">Amgen&#8217;s Gastric Cancer Drug Improves Survival In Phase 3, Notes Ocular Side Effects</a>
In April, the FDA approved a new option for patients to self-inject Argenx&#8217;s Vyvgart Hytrulo with a prefilled syringe for adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive and <a target="_blank" href="https://www.benzinga.com/25/04/44775384/fda-approves-argenxs-vyvgart-hytrulo-prefilled-syringe-for-self-injection-for-at-home-use-setting" rel="noreferrer noopener">adult patients with CIDP</a>.
In April, Argenx showcased long-term data of Vyvgart demonstrating sustained disease control of gMG and CIDP with a <a target="_blank" href="https://www.benzinga.com/25/04/44698379/argenxs-flagship-drug-vyvgart-shows-sustained-disease-control-in-rare-neuromuscular-disease-patients" rel="noreferrer noopener">favorable safety profile</a>.
<h2 class="wp-block-heading">Understanding Argenx&#8217;s Stock</h2>
Equity research can be a valuable source of information for learning about a company&#8217;s fundamentals. Analysts create financial models based on the fundamentals and expected future earnings of a company to arrive at a price target and recommendation for the stock.
Shares of Argenx have an average 1-year price target of $753.23, representing an expected upside of 43.52%.
Because of differences in assumptions, analysts can arrive at very different price targets and recommendations. No analysts have bearish recommendations on Argenx, while 13 analysts have bullish ratings. The street high price target from Guggenheim is $1065.0, while the street low from Baird is $680.0.
Equity research can be a valuable source of information for learning about a company&#8217;s fundamentals. Analysts create financial models based on the fundamentals and expected future earnings of a company to arrive at a price target and recommendation for the stock.
Shares of Argenx have an average 1-year price target of $753.23, representing an expected upside of 43.52%.
Because of differences in assumptions, analysts can arrive at very different price targets and recommendations. No analysts have bearish recommendations on Argenx, while 13 analysts have bullish ratings. The street high price target from Guggenheim is $1065.0, while the street low from Baird is $680.0.
Price Action: ARGX stock is down 6.56% at $523.37&nbsp;at the last check on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/health-care/25/06/46168811/modernas-mrna-flu-vaccine-outperforms-standard-shots" target="_blank" rel="noreferrer noopener">Moderna&#8217;s mRNA Flu Vaccine Outperforms Standard Shots</a></li>
</ul>
Photo by Tada Images via Shutterstock

Biotech

Large Cap

Health Care

Movers

General

ARGX

FDA Flags Major Safety Concerns For Argenx's Nerve Disorder Drug, Stock Falls

IonQ Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) shares are trading higher Monday afternoon after the company announced its commitment to helping build a quantum ecosystem in Texas.
The declaration <a href="https://www.benzinga.com/pressreleases/25/06/b46165057/texas-legislature-passes-ionq-supported-quantum-initiative-advancing-quantum-ecosystem-across-the-">follows the passage</a> of the Texas Quantum Initiative (HB 4751), new legislation designed to establish the state as a major hub for quantum innovation.
What To Know: The company says this engagement is part of IonQ&#8217;s broader vision to expand regional quantum economies. Earlier this year, IonQ CEO Niccolo de Masi testified before the Texas Senate Business and Commerce Committee, supporting the bill and emphasizing quantum&#8217;s role in future cybersecurity and economic challenges. 
&#8220;The Texas Quantum Initiative is more than just policy. It&#8217;s a platform for transformative innovation,&#8221; said de Masi. &#8220;IonQ is excited to collaborate with Texas leaders, universities, and industry.&#8221;
Per IonQ, the initiative creates a framework to leverage the state's academic and tech sectors through investment incentives and research opportunities. 
&#8220;Quantum technology is no longer a distant idea; it is quickly becoming a reality,&#8221; said Chairman Capriglione, a key supporter of the bill. He noted the initiative will help Texas lead in a globally competitive field.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, IONQ shares are trading higher by 7.98% to $43.46 during Monday&#8217;s session. IonQ&#8217;s short interest is high, with 20.89% of the company&#8217;s float, or 238.129 million shares, currently being sold short. The stock has a 52-week high of $54.74 and a 52-week low of $6.22.
Analyst Ratings: Recent <a href="https://www.benzinga.com/quote/IONQ/analyst-ratings">analyst ratings</a> for IonQ show a pattern of positive reinforcement. On June 30, an analyst at Benchmark reiterated their Buy rating for the stock, keeping the price target firm at $50. Earlier in the month, on June 11th, Needham also reiterated its Buy rating with a $50 price target.
Read Also: <a href="https://www.benzinga.com/markets/tech/25/06/46158257/quantum-stocks-surge-and-stumble-heres-what-happened-this-week">Quantum Stocks Surge And Stumble: Here&#8217;s What Happened This Week</a>
<h2 class="wp-block-heading">How To Buy IONQ Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in IonQ&#8217;s case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

IONQ

IonQ Stock Is Surging Monday: What's Driving The Rally?

Artificial intelligence stocks are on a heater in 2025.&nbsp;
Take Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), which is up 17.5% year-to-date and up 45.5% over the past three months. Then there's AI intelligence powerhouse CoreWeave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>), which is up a whopping 331% over the last 90 days alone. Or consider AI software developer Palantir (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), whose stock price is up 72.9% year-to-date and has increased by 405% over the past year.
Those are robust companies that have built a brand name for themselves in the AI realm and are obvious picks for investors looking to capitalize on the AI freight train of 2025. That said, they&#8217;re not the only names investors should be tracking in the AI market, especially after their rapid rise, which may make some investors concerned that most of the upside is behind them.
<h2 class="wp-block-heading">How The Pros Are Trading Strength Into Q3 — Live Today</h2>
Most traders chase headlines. The pros focus on trends that last. Today, Tuesday at 6 PM ET, see how Tim Melvin, Ryan Faloona, and Anne-Marie Baiynd are using market strength, momentum signals, and long-term setups to stay ahead of the next big move. Their tactics are precise and built for this market. Register <a href="https://benzinga.zoom.us/webinar/register/WN_OJ2FBspHSJSSVNlW8zGapw#/registration">HERE</a> now — limited seats available.
&#8220;This is the first inning of a nine-inning game for AI revolution, and the next generation of winners hasn't even been invented yet,&#8221; said Alan Haworth, senior financial advisor at Clare Market Investments. &#8220;The first round will be NVDA, MSFT, AMZN, GOOG, and a few other megacaps.&#8221;
For discerning investors, it's also a good idea to dig below the surface and uncover gems that aren't pure pay-play artificial intelligence stocks, but have ties to the AI sector.
 &#8220;2025 marks the start of stage two, where the operating and expansion layers are emerging as the real drivers of value,&#8221; said Shay Boloor, chief market strategist at Futurum Equities. &#8220;The explosive returns of phase one laid the tracks. But phase two is where we find compounding utility, and that's where the next decade of upside lives.&#8221;
Which companies indirectly tied to AI make the grade right now for technology investors at the mid-point of 2025? These stocks are getting a green light from market experts.
Astera Labs Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>). This Santa Clara, California-based semiconductor company specializes in solving AI and cloud computing data and network bottleneck issues. ALAB stock is down 31% year-to-date, but it's making up ground quickly. Over the past 90 days, the firm's stock price has increased by 52.5%, mainly due to its partnership with AIChip Technologies, a high-profile Taiwan-based chipmaker. &#8220;AI data centers are scaling laterally,&#8221; Boloor said. &#8221; Astera Labs owns the high-speed interconnects (PCIe, CXL, Ethernet) that make cluster performance viable.&#8221;
Astera Labs Inc. has a consensus price target of $ 97.50 based on the ratings of 15 analysts, as noted by Benzinga Ratings.
Oklo, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>). Oklo is carving a clear path to profit in the nuclear industry, providing clean energy through the design and deployment of fast-fission power plants. The company's stock is up 160.2% year-to-date as demand grows, driven by states like New York exploring new nuclear power initiatives and AI companies requiring more power for their data centers. &#8220;AI demands energy 24/7,&#8221; Bollor noted. &#8220;Small modular nuclear is no longer a fringe idea &#8211; it's foundational.&#8221;
Oklo has a consensus price target of $58.14, according to Benzinga Ratings.
Vistra Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>). This Texas-based power generator is essentially an AI infrastructure play as its nuclear plants provide the 24/7, reliable power sources that AI data centers require.
 &#8220;VST is currently trading at 12x forward earnings and, while they haven&#8217;t signed a data center deal yet, they&#8217;re well-positioned to do so in the immediate future especially following their $1.9B acquisition of seven natural gas-fired power plants that are set to add 2,600 megawatts of capacity across five states,&#8221; said Liam Hunt, director of research at IncomeInsider.org.
Vistra has a 95.5 Momentum Rating, according to Benzinga Ratings.
Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>). At first glance, this digital marketing and media services company may not seem like an obvious choice as an AI-linked company. Yet a closer look reveals that Adobe is doing a solid job of immersing agentic AI into the creative marketplace. Adobe&#8217;s Brand Concierge program and its AI-fueled workflow products and services are helping Adobe gain a solid foothold in the AI market, primarily through close partnerships with major industry players.
&#8220;Goldman Sachs puts ADBE among what it calls the top &#8216;Phase 3&#8217; AI monetizers,&#8221; said Dan Buckley, chief analyst at DayTrading.com. &#8220;These are firms generating revenue through AI, not just as speculative future promises, that are currently undervalued.&#8221;
Adobe has a consensus price target of $511.77, according to Benzinga Ratings.
<h2 class="wp-block-heading">Takeaway On AI Insider Stock Plays</h2>
The message for Main Street investors is clear and direct: stop chasing the obvious AI names and focus on the &#8216;picks and shovels&#8217; plays.
&#8220;Identify companies that benefit from AI adoption and scaling without trading at AI valuations,&#8221; Hunt said. &#8220;Utilities with data center exposure offer growth potential that tracks the AI boom at a more reasonable price point. Additionally, energy infrastructure plays have a strong chance of outperforming the mega-cap tech stocks everyone&#8217;s watching.&#8221;
&#8220;In short, diversify across the AI value chain rather than betting everything on chip stocks,&#8221; he added.
Editorial content from our expert contributors is intended to be information for the general public and not individualized investment advice. Editors/contributors are presenting their individual opinions and strategies, which are neither expressly nor impliedly approved or endorsed by Benzinga.
Photo: Shutterstock

Opinion

ADBE

ALAB

CRWV

NVDA

OKLO

PLTR

4 Fast-Rising AI Stocks You Probably Haven't Heard Of

U.S. equities opened higher on the final trading day of the first half, with tech-heavy indexes extending record highs by midday <a href="https://www.benzinga.com/markets">trading in New York.</a>
Risk appetite remained firm as geopolitical tensions eased and hopes grew that upcoming U.S. trade talks could yield tangible progress. Market sentiment was further supported by rising expectations of a Federal Reserve rate cut, with Fed futures currently assigning a 93% chance of a rate cut in September.
The S&amp;P 500 and Nasdaq 100 rose 0.4% and 0.6%, respectively, while the Dow Jones Industrial Average climbed nearly 200 points, breaking above the 44,000 mark.
President Donald Trump signaled openness to extending the July 9 deadline for reinstating reciprocal tariffs, adding that he remained optimistic about reaching key agreements in the coming weeks. Meanwhile, Canada's withdrawal of its digital services tax helped improve the outlook for U.S. tech firms and reignited momentum in trade negotiations with Washington.
In currency markets, the U.S. Dollar Index is set for its fifth consecutive monthly decline, marking its longest losing streak since 2017 and its worst half-year performance since 1991, with a 10.5% drop year-to-date.
Treasury yields edged lower, with the 10-year yield dipping to 4.25% and the 30-year yield retreating to 4.80%, snapping a three-month streak of increases.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) slipped 1% to $107,330, consolidating after a strong second-quarter rally of 30%.
See Also: <a href="https://www.benzinga.com/markets/forex/25/06/46175116/weaker-dollar-stocks-beneficiaries-foreign-revenue">Dollar&#8217;s Biggest Crash In Decades: These 7 Stocks Could Win Big</a>
<h1 class="wp-block-heading">Monday&#8217;s Performance In Major US Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day chg. %</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>22,668.63</td>
<td>0.6%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,027.78</td>
<td>0.5%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,196.12</td>
<td>0.4%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,173.65</td>
<td>0.1 %</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:40 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.4% to $617.00.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.5% to $440.00.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;soared 0.5% to $550.93.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) inched 0.2% higher $215.86.</li>
<li>The&nbsp;Technology&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, up 0.8%; the&nbsp;Consumer Discretionary&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) lagged, down 0.6%.</li>
</ul>
<h1 class="wp-block-heading">Monday&#8217;s Stock Movers</h1>
<ul class="wp-block-list">
<li>Hewlett Packard Enterprise (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) shares jumped 13% after reaching a settlement with the U.S. Department of Justice over its $14 billion acquisition of Juniper Networks Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNPR#NYSE">JNPR</a>), pending final court approval.</li>
<li>First Solar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) shares rose 9% to $163 after the U.S. Senate advanced a bill preserving solar leasing tax credits.</li>
<li>Other solar stocks also rallied, with SolarEdge Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>), up 5% and SunRun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>), up 15%. Read now:</li>
<li><a href="https://www.benzinga.com/news/25/06/46171994/emerging-markets-stocks-dollar-outlook">A Weaker Dollar Just Unlocked A Surprise 2025 Winner — And Smart Money Is Moving In</a> Photo: khunkornStudio via Shutterstock</li>
</ul>

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Tech

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

FSLR

JNPR

SEDG

Select Sector SPDR-Consumer Discretionary

Wall Street Extends Record Highs, Dow Jones Hits 44,000: What's Driving Markets Monday?

<a href="https://truthsocial.com/@realDonaldTrump/posts/114773418889111055" title="https://truthsocial.com/@realDonaldTrump/posts/114773418889111055">https://truthsocial.com/@realDonaldTrump/posts/114773418889111055</a>

Federal Reserve

President Trump Posts On Truth Social "Jerome "Too Late" Powell, and his entire Board, should be ashamed of themselves for allowing this to happen to the United States. They have one of the easiest, yet most prestigious, jobs in America, and they have FAILED — And continue to do so. If they were doing their job properly, our Country would be saving Trillions of Dollars in Interest Cost. The Board just sits there and watches, so they are equally to blame. We should be paying 1% Interest, or better!"

B of A Securities analyst Craig Siegenthaler initiates coverage on Cohen &amp; Steers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNS#NYSE">CNS</a>) with a Underperform rating and announces Price Target of $67.

Price Target

Initiation

B of A Securities Initiates Coverage On Cohen & Steers with Underperform Rating, Announces Price Target of $67

<h3>Gainers</h3>
<ul>
<li>Genius Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) shares moved upwards by 49.2% to $1.47 during Monday's regular session. The market value of their outstanding shares is at $70.4 million. </li>
<li>Newegg Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) shares moved upwards by 25.57% to $15.17. The company's market cap stands at $235.2 million. </li>
<li>Ruanyun Edai Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) shares moved upwards by 22.92% to $7.56. The company's market cap stands at $207.5 million. </li>
<li>Wag Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) stock increased by 21.52% to $0.13. The market value of their outstanding shares is at $5.3 million. </li>
<li>Lifetime Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCUT#NASDAQ">LCUT</a>) stock rose 19.42% to $5.2. The company's market cap stands at $97.5 million. </li>
<li>Noodles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDLS#NASDAQ">NDLS</a>) shares increased by 18.68% to $0.72. The market value of their outstanding shares is at $27.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Dogness (Intl) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOGZ#NASDAQ">DOGZ</a>) stock decreased by 34.5% to $18.68 during Monday's regular session. The market value of their outstanding shares is at $406.1 million. </li>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) stock declined by 15.8% to $0.5. </li>
<li>Allied Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGAE#NASDAQ">AGAE</a>) shares decreased by 14.61% to $2.69. The company's market cap stands at $138.9 million. </li>
<li>Century Casinos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTY#NASDAQ">CNTY</a>) shares declined by 13.66% to $2.06. The company's market cap stands at $73.0 million. </li>
<li>Emerson Radio (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MSN#AMEX">MSN</a>) stock decreased by 13.09% to $0.34. The market value of their outstanding shares is at $8.1 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>707 Cayman Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JEM#NASDAQ">JEM</a>) shares declined by 11.43% to $5.58. The market value of their outstanding shares is at $138.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AGAE

CNTY

DOGZ

LCUT

MULN

NDLS

NEGG

RYET

12 Consumer Discretionary Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Artelo Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTL#NASDAQ">ARTL</a>) shares moved upwards by 113.0% to $14.46 during Monday's regular session. The market value of their outstanding shares is at $3.7 million. </li>
<li>Klotho Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) stock increased by 61.1% to $1.16. The market value of their outstanding shares is at $26.2 million. </li>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) shares rose 54.24% to $1.64. The market value of their outstanding shares is at $132.4 million. </li>
<li>Know Labs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KNW#AMEX">KNW</a>) stock rose 33.94% to $2.13. The company's market cap stands at $11.8 million. </li>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) stock moved upwards by 24.27% to $0.64. The company's market cap stands at $15.7 million. </li>
<li>Acurx Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACXP#NASDAQ">ACXP</a>) stock moved upwards by 22.97% to $0.53. The market value of their outstanding shares is at $10.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>INmune Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMB#NASDAQ">INMB</a>) shares decreased by 59.9% to $2.14 during Monday's regular session. The company's market cap stands at $124.6 million. </li>
<li>Unity Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBX#NASDAQ">UBX</a>) shares decreased by 31.55% to $0.53. The market value of their outstanding shares is at $13.2 million. </li>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) stock declined by 30.27% to $0.06. The company's market cap stands at $32.7 million. </li>
<li>Sera Prognostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERA#NASDAQ">SERA</a>) stock decreased by 29.96% to $2.87. The company's market cap stands at $154.0 million. </li>
<li>Unicycive Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNCY#NASDAQ">UNCY</a>) stock declined by 27.8% to $4.91. The market value of their outstanding shares is at $82.0 million. </li>
<li>Odysight ai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODYS#NASDAQ">ODYS</a>) shares decreased by 27.44% to $5.09. The company's market cap stands at $114.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACXP

ARTL

INMB

KLTO

NCNA

ODYS

ONMD

SERA

UNCY

12 Health Care Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Professional Diversity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPDN#NASDAQ">IPDN</a>) stock moved upwards by 86.3% to $3.26 during Monday's regular session. The company's market cap stands at $3.6 million. </li>
<li>OneConstruction Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEG#NASDAQ">ONEG</a>) stock moved upwards by 38.58% to $6.86. The market value of their outstanding shares is at $64.3 million. </li>
<li>Plug Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares moved upwards by 34.67% to $1.56. The market value of their outstanding shares is at $1.3 billion. </li>
<li>Phoenix Asia Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHOE#NASDAQ">PHOE</a>) stock rose 29.03% to $9.2. The company's market cap stands at $154.0 million. </li>
<li>JVSPAC Acquisition Corp. - Right (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSAR#NASDAQ">JVSAR</a>) stock rose 26.61% to $0.79. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) shares rose 21.47% to $0.12. The company's market cap stands at $14.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>JVSPAC Acquisition (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSA#NASDAQ">JVSA</a>) stock fell 64.7% to $3.78 during Monday's regular session. The company's market cap stands at $82.2 million. </li>
<li>JVSPAC Acquisition (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSAU#NASDAQ">JVSAU</a>) stock fell 59.0% to $5.0. </li>
<li>WF Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFF#NASDAQ">WFF</a>) stock fell 41.11% to $2.35. The company's market cap stands at $100.5 million. </li>
<li>Fortive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>) stock declined by 28.18% to $51.43. The company's market cap stands at $24.3 billion. </li>
<li>374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) shares declined by 16.82% to $0.29. The market value of their outstanding shares is at $49.7 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) shares decreased by 16.01% to $0.04. The market value of their outstanding shares is at $1.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IPDN

JVSA

JVSAR

JVSAU

ONEG

PHOE

PLUG

SCWO

WLGS

12 Industrials Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>BitMine Immersion Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#AMEX">BMNR</a>) shares increased by 492.3% to $25.26 during Monday's regular session. The market value of their outstanding shares is at $25.8 million. </li>
<li>Blaize Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) shares rose 26.81% to $2.98. The company's market cap stands at $238.9 million. </li>
<li>BigBear.ai Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) shares rose 22.59% to $7.16. The market value of their outstanding shares is at $1.6 billion. </li>
<li>AstroNova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALOT#NASDAQ">ALOT</a>) shares rose 21.92% to $11.34. The market value of their outstanding shares is at $70.6 million. </li>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) stock moved upwards by 17.26% to $1.05. The market value of their outstanding shares is at $17.2 million. </li>
<li>Cloudastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSAI#NASDAQ">CSAI</a>) shares increased by 15.55% to $2.2. The market value of their outstanding shares is at $32.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) shares declined by 55.2% to $0.16 during Monday's regular session. The company's market cap stands at $37.5 million. </li>
<li>Argo Blockchain plc - 8.75% Senior Notes due 2026 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBKL#NASDAQ">ARBKL</a>) stock declined by 51.64% to $3.24. </li>
<li>Argo Blockchain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) shares fell 43.16% to $0.21. The market value of their outstanding shares is at $23.1 million. </li>
<li>Locafy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCFY#NASDAQ">LCFY</a>) stock declined by 33.38% to $5.53. The market value of their outstanding shares is at $10.5 million. </li>
<li>Ascent Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) shares fell 17.91% to $2.66. The company's market cap stands at $5.8 million. </li>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) shares fell 16.03% to $13.71. The market value of their outstanding shares is at $28.6 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALOT

ARBK

Argo Blockchain plc - 8.75% Senior Notes due 2026

ARBKL

ASTI

BBAI

BMNR

BZAI

CSAI

LCFY

LIDR

12 Information Technology Stocks Moving In Monday's Intraday Session

B of A Securities analyst Wamsi Mohan maintains Hewlett Packard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) with a Buy and raises the price target from $20 to $23.

B of A Securities Maintains Buy on Hewlett Packard, Raises Price Target to $23

D. Boral Capital analyst Jason Kolbert maintains Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) with a Buy and maintains $23 price target.

CLNN

D. Boral Capital Maintains Buy on Clene, Maintains $23 Price Target

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Ascendiant Capital analyst Edward Woo initiated coverage on Aytu BioPharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) with a Buy rating and announced a price target of $12. Aytu BioPharma shares closed at $2.10 on Friday. <a href="https://www.benzinga.com/quote/aytu/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham analyst John Todaro initiated coverage on Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) with a Buy rating and announced a price target of $250. Circle Internet shares closed at $180.43 on Friday. <a href="https://www.benzinga.com/quote/crcl/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Joseph Pantginis initiated coverage on Edgewise Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWTX#NASDAQ">EWTX</a>) with a Buy rating and announced a price target of $42. Edgewise Therapeutics shares closed at $13.17 on Friday. <a href="https://www.benzinga.com/quote/ewtx/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>CICC analyst Sijie Lin initiated coverage on Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) with an Outperform rating and announced a price target of $100. Starbucks shares closed at $92.11 on Friday. <a href="https://www.benzinga.com/quote/sbux/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Cantor Fitzgerald analyst Jonathan Ruykhaver initiated coverage on SailPoint, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIL#NASDAQ">SAIL</a>) with an Overweight rating and announced a price target of $29. SailPoint shares closed at $22.77 on Friday. <a href="https://www.benzinga.com/quote/sail/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying SBUX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/SBUX/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="568" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30130225/image-445-1024x568.png" alt="" class="wp-image-967324" style="width:608px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30130225/image-445-1024x568.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30130225/image-445-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30130225/image-445-768x426.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/30130225/image-445.png 1118w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/46136470/jim-cramer-just-revealed-1-oil-stock-he-actually-wants-to-own">Jim Cramer Just Revealed 1 Oil Stock He Actually Wants To Own</a> </li>
</ul>
Photo via Shutterstock

AYTU

CRCL

EWTX

SAIL

SBUX

This Starbucks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Lakeland Industries, Inc. ("Lakeland Fire + Safety" or "Lakeland") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAKE#NASDAQ">LAKE</a>), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced that it has been added to the broad-market Russell 3000&#xAE; Index and Russell 2000&#xAE; Index effective after the U.S. market close on June 27, 2025, as part of FTSE Russell's annual reconstitution.

LAKE

Lakeland Industries Added To Russell 3000 And Russell 2000 Indexes

CN Plans To Invest ~$38M In Iowa, As Part Of 2025 Capital Investment Program

AMAT

MELI

CNBC Halftime Report Final Trades: UnitedHealth Group, MercadoLibre, Applied Materials

Press Releases

DIVIDEND DISTRIBUTION PROPOSAL

FERRARI RELEASES ITS 2024 ANNUAL REPORT AND FILES ANNUAL REPORT ON FORM 20-F

Ferrari: Announcement of the Seventh Tranche of the Multi-Year Share Repurchase Program by Participating as a Purchaser in Exor's Accelerated Bookbuild Offering

FERRARI PARTICIPATED AS A PURCHASER IN EXOR'S ACCELERATED BOOKBUILD OFFERING

FERRARI PUBLISHES AGENDA FOR THE 2025 AGM

Ferrari N.v.: Completion of the Seventh Tranche of the Multi-Year Share Repurchase Program

Comments

Ferrari

Actualités

Dernières nouvelles pour Ferrari (NYSE:RACE) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL